121 related articles for article (PubMed ID: 10800089)
1. Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector.
Hiller C; Wittmann S; Slavin S; Fickenscher H
Gene Ther; 2000 Apr; 7(8):664-74. PubMed ID: 10800089
[TBL] [Abstract][Full Text] [Related]
2. T cell transduction and suicide with an enhanced mutant thymidine kinase.
Qasim W; Thrasher AJ; Buddle J; Kinnon C; Black ME; Gaspar HB
Gene Ther; 2002 Jun; 9(12):824-7. PubMed ID: 12040465
[TBL] [Abstract][Full Text] [Related]
3. Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus.
Hiller C; Tamgüney G; Stolte N; Mätz-Rensing K; Lorenzen D; Hör S; Thurau M; Wittmann S; Slavin S; Fickenscher H
Virology; 2000 Dec; 278(2):445-55. PubMed ID: 11118367
[TBL] [Abstract][Full Text] [Related]
4. Herpesvirus saimiri.
Fickenscher H; Fleckenstein B
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):545-67. PubMed ID: 11313011
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
[TBL] [Abstract][Full Text] [Related]
6. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
Yang J; Liu TJ; Lu Y
Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
[TBL] [Abstract][Full Text] [Related]
7. Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis.
Painter RG; Lanson NA; Jin Z; Park F; Wang G
Cancer Sci; 2005 Sep; 96(9):607-13. PubMed ID: 16128746
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir.
Wang S; Qi J; Smith M; Link CJ
Cancer Gene Ther; 2002 Jan; 9(1):1-8. PubMed ID: 11916238
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes.
Junker K; Koehl U; Zimmerman S; Stein S; Schwabe D; Klingebiel T; Grez M
Gene Ther; 2003 Jul; 10(14):1189-97. PubMed ID: 12833128
[TBL] [Abstract][Full Text] [Related]
10. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
[TBL] [Abstract][Full Text] [Related]
11. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
12. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
13. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
14. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector.
Hoggarth JH; Jones E; Ensser A; Meredith DM
Cancer Gene Ther; 2004 Sep; 11(9):613-24. PubMed ID: 15243631
[TBL] [Abstract][Full Text] [Related]
16. A DNA recombination-based approach to eliminate papillomavirus infection.
Carson A; Wang Z; Xiao X; Khan SA
Gene Ther; 2005 Mar; 12(6):534-40. PubMed ID: 15756291
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
Wildner O; Hoffmann D; Jogler C; Uberla K
Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
19. Absence of in vitro or in vivo bystander effects in a thymidine kinase-transduced murine T lymphoma.
Rivas C; Chandler P; Melo JV; Simpson E; Apperley JF
Cancer Gene Ther; 2000 Jun; 7(6):954-62. PubMed ID: 10880028
[TBL] [Abstract][Full Text] [Related]
20. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
